The most efficacy drug therapy employed to treat Parkinson's disease is the levodopa but, for obscure reasons, after few years this induces motor complications called dyskinesias. The Institute of Bioimaging and Molecular Physiology-CNR of Catanzaro, in collaboration with the Institute of Neurology of the Policlinico "Magna Graecia" Catanzaro, has shed new light on the neurobiological correlates of this motor complication demonstrating the efficacy of neurostimulation. This research has been published on the scientific journal "Brain".
Cerasa A, Koch G, Donzuso G, Mangone G, Morelli M, Brusa L, Stampanoni Bassi M , Ponzo V, Picazio S, Passamonti L, Salsone M, Augimeri A, Caltagirone C, Quattrone A. A network centred on the inferior frontal
cortex is critical for inducing levodopa-induced dyskinesias. Brain, 2015; 138 (Pt 2): 414-427. DOI: 10.1093/brain/awu329
Focus